Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age: from 20 - 35 years old.~* Pregnant from 30 week to 32 week gestation.~* Singleton pregnancy with asymmetrical intrauterine growth restriction .~* Normal uterine and umbilical Doppler indices at time of recruitment.~Exclusion Criteria:~* Multiple gestations.~* Hypertensive women.~* Premature rupture of membranes.~* Abnormal Doppler indices in the form of Doppler blood flow indices \> 2 standard deviation , absent diastolic flow and lastly; reversed flow.~* Congenital fetal malformation.~* Pregnancy complicated by antepartum hemorrhage.~* Marked decrease in Amniotic fluid volume.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- Low dose aspirin (Type: ACTIVE_COMPARATOR): Received aspirin 81mg once daily for 6 weeks
- Low dose aspirin plus omega 3 group (Type: ACTIVE_COMPARATOR): Received aspirin 81mg and omega 3 once daily for 6 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).